Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
45,148,065
-
Total 13F shares
-
23,065,711
-
Share change
-
+23,062,256
-
Total reported value
-
$405,121,994
-
Price per share
-
$17.56
-
Number of holders
-
74
-
Value change
-
+$405,061,184
-
Number of buys
-
73
Institutional Holders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) as of Q4 2025
As of 31 Dec 2025,
MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,065,711 shares.
The largest 10 holders included
NOVO HOLDINGS A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., GOLDMAN SACHS GROUP INC, BlackRock, Inc., Nan Fung Group Holdings Ltd, 5AM Venture Management, LLC, Sanofi, VANGUARD GROUP INC, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.